tiprankstipranks
Trending News
More News >
Replicel (REPCF)
:REPCF
US Market
Advertisement

RepliCel Life Sciences (REPCF) Income Statement

Compare
22 Followers

RepliCel Life Sciences Income Statement

Last quarter (Q2 2025), RepliCel Life Sciences's total revenue was C$0.00, a decrease of -100.00% from the same quarter last year. In Q2, RepliCel Life Sciences's net income was C$-28.65K. See RepliCel Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 353.74KC$ 353.74KC$ 353.74KC$ 353.74KC$ 353.74K
Gross Profit
C$ 353.74KC$ 352.26KC$ 353.74KC$ 353.74KC$ 353.74K
Operating Expenses
C$ 713.82KC$ 1.74MC$ 1.75MC$ 2.65MC$ 1.68M
Depreciation and Amortization
C$ 541.00C$ 1.47KC$ 839.00C$ 1.15KC$ 1.57K
EBITDA
C$ -360.00KC$ -1.39MC$ -736.00KC$ -4.07MC$ -1.58M
Operating Income
C$ -360.00KC$ -1.39MC$ -1.39MC$ -2.30MC$ -1.33M
Other Income/Expenses
C$ 262.80KC$ 1.07MC$ 649.47KC$ -1.77MC$ -252.02K
Pretax Income
C$ -97.29KC$ -312.00KC$ -743.00KC$ -4.07MC$ -1.58M
Net Income
C$ -97.29KC$ -312.00KC$ -743.00KC$ -4.07MC$ -1.58M
Per Share Metrics
Basic EPS
C$ 0.00C$ -0.01C$ -0.02C$ -0.13C$ -0.06
Diluted EPS
C$ 0.00C$ -0.01C$ -0.02C$ -0.13C$ -0.06
Weighted Average Shares Outstanding
62.29M 59.24M 37.77M 32.49M 26.96M
Weighted Average Shares Outstanding (Diluted)
62.25M 59.24M 37.77M 32.49M 26.96M
Currency in CAD

RepliCel Life Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis